Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 25 2024

Full Issue

Viewpoints: There May Be A Dark Side To New Weight-Loss Drugs; Should THC Levels Be Regulated?

Editorial writers delve into weight-loss drugs, high potency marijuana, abortion restrictions, and prior authorizations.

In 1998, Viagra received FDA approval. A financial bonanza followed for its manufacturer, Pfizer, and later for its competitors. Although initially approved—and marketed—specifically for erectile dysfunction, Pfizer and later competitors used aggressive targeted marketing to catapult the drug from an erectile dysfunction treatment to a lifestyle pill pocketed by nervous 30-year-olds heading out on Internet dates. (Arthur Caplan ,1/24)

The debate over prohibition should be settled law. Banning marijuana doesn’t work. But federal and state regulators should make rules governing legal marijuana products to protect public health, just as they do with any other food, drink, and drug. That may mean considering imposing additional potency limits, while ensuring that consumers know, through accurate labeling and education, what they are ingesting. (1/25)

When 53% of Tennessee voters agreed to remove state constitutional protections for abortion, they were not asked if they wanted to criminalize the delivery of healthcare, difficult pregnancies or the desperation of a pregnant minor to obtain reproductive care. (David Plazas, 1/24)

Imagine this scene: You are a cancer patient already navigating fear and uncertainty around your treatment, when you inexplicably cannot access the care recommended by your cancer doctor. This turns out to be because of a perverse hurdle imposed by your insurance company — called a prior authorization — that ends in a denial of care. (Tina Shah and Devika Bhushan, 1/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ